Oslo, Norway

Anne So Slashednstevold

This inventor holds 1 USPTO granted patent. Top assignee: Nycomed Imaging as. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne So Slashednstevold: Innovator in Medical Treatments

Introduction

Anne So Slashednstevold is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of medical treatments, particularly through her innovative approach to addressing the side effects of particulate drugs. Her work has the potential to improve patient outcomes and enhance the efficacy of drug administration.

Latest Patents

Anne holds a patent for the "Use of nitric oxide inhibitors for treating side effects of particulate." This invention describes the use of a nitric oxide synthetase inhibitor or nitric oxide antagonist to reduce or eliminate unwanted physiological effects encountered with the parenteral administration of particulate drugs. This patent highlights her commitment to advancing medical science and improving therapeutic methods.

Career Highlights

Anne is currently employed at Nycomed Imaging AS, where she continues to develop her innovative ideas and contribute to the field of medical imaging and treatment. Her role at the company allows her to collaborate with other experts and push the boundaries of current medical technologies.

Collaborations

Anne has worked alongside her coworker, Jonny O Slashedstensen, to further enhance their research and development efforts. Their collaboration exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in medical science.

Conclusion

Anne So Slashednstevold is a trailblazer in the field of medical inventions, with her patent on nitric oxide inhibitors showcasing her innovative spirit. Her work at Nycomed Imaging AS and collaboration with colleagues further solidify her impact on the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…